Acura Pharmaceuticals, Inc. is a publicly traded company. Effective February 4, 2008, Acura's common shares are listed under the stock symbol ACUR on the NASDAQ Capital Market® ("NASDAQ"). Prior to being listed on the NASDAQ, the common shares were listed on the Over-The-Counter Bulletin Board (OTCBB)® with stock symbol ACPH.OB.

The Securities and Exchange Commission (SEC) Central Index Key (CIK) is: 0000786947.

On December 4, 2007, the Company announced implementation of a 1-for-10 reverse stock split commencing December 5, 2007. Each shareholder of record was mailed a Reverse Split Letter and Transmittal Notice containing details to exchange your old certificates.

We encourage all current and potential new investors to review our SEC filings and Press Releases. Investor inquiries may be made to Peter A. Clemens, the Company's Senior Vice President of Investor Relations and Chief Financial Officer. 

You may click on  ACUR to access the Company's stock price from Yahoo® and click on the links below to access our recent SEC filings.